John M. Varlotto

1.7k total citations
54 papers, 1.3k citations indexed

About

John M. Varlotto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, John M. Varlotto has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 9 papers in Genetics. Recurrent topics in John M. Varlotto's work include Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Diagnosis and Treatment (25 papers) and Glioma Diagnosis and Treatment (9 papers). John M. Varlotto is often cited by papers focused on Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Diagnosis and Treatment (25 papers) and Glioma Diagnosis and Treatment (9 papers). John M. Varlotto collaborates with scholars based in United States, Israel and Canada. John M. Varlotto's co-authors include John C. Flíckinger, Abram Recht, Malcolm M. DeCamp, Laura N. Medford‐Davis, Douglas Kondziolka, Ajay Bhatnagar, Ajay Niranjan, Margaret C. Nikolov, L. Dade Lunsford and George Iliakis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and CHEST Journal.

In The Last Decade

John M. Varlotto

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John M. Varlotto United States	21	754	433	382	252	222	54	1.3k
Sabine Haufe Germany	17	653 0.9×	445 1.0×	515 1.3×	98 0.4×	165 0.7×	32	1.5k
D.N. Yeboa United States	16	476 0.6×	279 0.6×	176 0.5×	311 1.2×	163 0.7×	86	936
C.F. Hess Germany	17	361 0.5×	417 1.0×	154 0.4×	150 0.6×	449 2.0×	50	1.2k
David Pistenmaa United States	14	829 1.1×	121 0.3×	130 0.3×	453 1.8×	113 0.5×	35	1.3k
Keith Unger United States	17	373 0.5×	398 0.9×	136 0.4×	85 0.3×	275 1.2×	64	940
Asha Kandathil United States	11	301 0.4×	204 0.5×	154 0.4×	162 0.6×	588 2.6×	34	1.2k
Paola Mapelli Italy	21	593 0.8×	282 0.7×	194 0.5×	54 0.2×	105 0.5×	89	1.2k
Myung‐Ju Ahn South Korea	20	990 1.3×	792 1.8×	165 0.4×	32 0.1×	175 0.8×	75	1.5k
Takehiro Okumura Japan	19	572 0.8×	373 0.9×	111 0.3×	29 0.1×	236 1.1×	45	1.0k
R. Semrau Germany	23	478 0.6×	493 1.1×	77 0.2×	74 0.3×	564 2.5×	59	1.3k

Countries citing papers authored by John M. Varlotto

Since Specialization

Citations

This map shows the geographic impact of John M. Varlotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Varlotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Varlotto more than expected).

Fields of papers citing papers by John M. Varlotto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Varlotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Varlotto. The network helps show where John M. Varlotto may publish in the future.

Co-authorship network of co-authors of John M. Varlotto

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Varlotto. A scholar is included among the top collaborators of John M. Varlotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Varlotto. John M. Varlotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Varlotto, John M., Dani S. Zander, Malcolm M. DeCamp, et al.. (2024). Lymphatic vascular invasion: Diagnostic variability and overall survival impact on patients undergoing surgical resection. JTCVS Open. 21. 313–340.

Varlotto, John M., et al.. (2022). Bevacizumab’s Association With a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505, a Phase 3 Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab in Surgically Resected NSCLC. JTO Clinical and Research Reports. 3(3). 100274–100274. 5 indexed citations

Febres‐Aldana, Christopher A., et al.. (2020). Diabetes mellitus type 2 is associated with increased tumor expression of programmed death-ligand 1 (PD-L1) in surgically resected non-small cell lung cancer—A matched case-control study. Cancer Treatment and Research Communications. 23. 100170–100170. 10 indexed citations

Varlotto, John M., Malcolm M. DeCamp, Paul Rava, et al.. (2020). The rates of second lung cancers and the survival of surgically-resected second primary lung cancers in patients undergoing resection of an initial primary lung cancer. Lung Cancer. 147. 115–122. 7 indexed citations

Varlotto, John M., John C. Flíckinger, Malcolm M. DeCamp, et al.. (2018). Population‐based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease. Cancer Medicine. 7(4). 1211–1220. 23 indexed citations

Varlotto, John M., Suzanne E. Dahlberg, Heather A. Wakelee, Suresh S. Ramalingam, & Joan H. Schiller. (2017). Risk factors associated with brain metastases in ECOG-ACRIN E1505, a phase III randomized trial of adjuvant chemotherapy with or without bevacizumab for patients with completely resected stage IB (>/= 4 cm) - IIIA non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 35(15_suppl). 8539–8539. 2 indexed citations

Yang, Xuebin, Yong-Jun Liu, Haresh Mani, et al.. (2016). Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer. Pathology & Oncology Research. 23(1). 73–77. 13 indexed citations

Huang, Lisa, Nengliang Yao, Jianying Zhang, et al.. (2016). Adjuvant chemotherapy and radiation options and their associated outcomes in surgically-resected non-small cell carcinoma.. Journal of Clinical Oncology. 34(15_suppl). e20001–e20001. 1 indexed citations

Gilbert, Christopher R., Jennifer Toth, Jussuf T. Kaifi, et al.. (2013). Endobronchial Valve Placement for Spontaneous Pneumothorax From Stage IIIA Non-Small Cell Lung Cancer Facilitates Neoadjuvant Therapy. The Annals of Thoracic Surgery. 96(6). 2225–2227. 4 indexed citations

10.

Kelsey, Chris R., Kristin Higgins, Bercedis L. Peterson, et al.. (2013). Local recurrence after surgery for non–small cell lung cancer: A recursive partitioning analysis of multi-institutional data. Journal of Thoracic and Cardiovascular Surgery. 146(4). 768–773.e1. 14 indexed citations

11.

Andrei, Adin‐Cristian, John M. Varlotto, Julia Shelkey, et al.. (2012). Statin Use Is Associated With Decreased Local Recurrence and Improved Overall Survival in Resectable Non-small Cell Lung Cancer (NSCLC). CHEST Journal. 142(4). 925A–925A. 7 indexed citations

12.

Varlotto, John M., Laura N. Medford‐Davis, Abram Recht, et al.. (2011). Should Large Cell Neuroendocrine Lung Carcinoma be Classified and Treated as a Small Cell Lung Cancer or with Other Large Cell Carcinomas?. Journal of Thoracic Oncology. 6(6). 1050–1058. 77 indexed citations

13.

Varlotto, John M., Abram Recht, John C. Flíckinger, et al.. (2011). Lobectomy leads to optimal survival in early-stage small cell lung cancer: A retrospective analysis. Journal of Thoracic and Cardiovascular Surgery. 142(3). 538–546. 64 indexed citations

14.

Varlotto, John M., Laura N. Medford‐Davis, Abram Recht, et al.. (2011). Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer. Lung Cancer. 75(3). 381–390. 31 indexed citations

15.

Varlotto, John M., Laura N. Medford‐Davis, Abram Recht, et al.. (2010). Failure Rates and Patterns of Recurrence in Patients With Resected N1 Non–Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 81(2). 353–359. 22 indexed citations

16.

Varlotto, John M., Abram Recht, John C. Flíckinger, et al.. (2010). Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I nonsmall cell lung cancer. Cancer. 116(10). 2390–2400. 43 indexed citations

17.

Varlotto, John M., et al.. (2009). Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer. Cancer. 115(5). 1059–1069. 85 indexed citations

18.

Varlotto, John M., John C. Flíckinger, Abram Recht, Margaret C. Nikolov, & Malcolm M. DeCamp. (2008). A comparison of survival and disease‐specific survival in surgically resected, lymph node‐positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer. Cancer. 112(7). 1547–1554. 13 indexed citations

19.

Varlotto, John M., Kristina Gerszten, Dwight E. Heron, et al.. (2006). The Potential Nephrotoxic Effects of Intensity Modulated Radiotherapy Delivered to the Para-Aortic Area of Women With Gynecologic Malignancies. American Journal of Clinical Oncology. 29(3). 281–289. 6 indexed citations

20.

Varlotto, John M., John C. Flíckinger, Ajay Niranjan, et al.. (2005). The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. International Journal of Radiation Oncology*Biology*Physics. 62(4). 1125–1132. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact